PReS-FINAL-2166: Long-term safety and effectiveness of anti-interleukin-6 receptor monoclonal antibody, tocilizumab, in patients with systemic juvenile idiopathic arthritis in Japan

被引：0
|
作者：
S Yokota
T Nozawa
T Kanetaka
K Yamazaki
T Sato
N Sakurai
M Kikuchi
机构：
[1] Yokohama City University School of Medicine,Department of Pediatrics
来源：
Pediatric Rheumatology | / 11卷 / Suppl 2期
关键词：
Juvenile Idiopathic Arthritis; Tocilizumab; Corticosteroid Dose; Systemic Juvenile Idiopathic Arthritis; Patent Holder;
D O I：
10.1186/1546-0096-11-S2-P178
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Longterm Safety and Effectiveness of the Anti-interleukin 6 Receptor Monoclonal Antibody Tocilizumab in Patients with Systemic Juvenile Idiopathic Arthritis in Japan
    Yokota, Shumpei
    Imagawa, Tomoyuki
    Mori, Masaaki
    Miyamae, Takako
    Takei, Syuji
    Iwata, Naomi
    Umebayashi, Hiroaki
    Murata, Takuji
    Miyoshi, Mari
    Tomiita, Minako
    Nishimoto, Norihiro
    Kishimoto, Tadamitsu
    [J]. JOURNAL OF RHEUMATOLOGY, 2014, 41 (04) : 759 - 767
  • [2] Improvement of reduced serum cartilage oligomeric matrix protein levels in systemic juvenile idiopathic arthritis patients treated with the anti-interleukin-6 receptor monoclonal antibody tocilizumab
    Nakajima, Shoko
    Naruto, Takuya
    Miyamae, Takako
    Imagawa, Tomoyuki
    Mori, Masaaki
    Nishimaki, Shigeru
    Yokota, Shumpei
    [J]. MODERN RHEUMATOLOGY, 2009, 19 (01) : 42 - 46
  • [3] Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis
    Koike, Ryuji
    Harigai, Masayoshi
    Atsumi, Tatsuya
    Amano, Koichi
    Kawai, Shinichi
    Saito, Kazuyoshi
    Saito, Tomoyuki
    Yamamura, Masahiro
    Matsubara, Tsukasa
    Miyasaka, Nobuyuki
    [J]. MODERN RHEUMATOLOGY, 2009, 19 (04) : 351 - 357
  • [4] Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis
    Okuda, Yasuaki
    Takasugi, Kiyoshi
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : 2997 - 3000
  • [5] Long-term treatment of systemic onset juvenile idiopathic arthritis (SO-JIA) with humanized anti-IL-6 receptor monoclonal antibody, tocilizumab (Actemra®)
    Yokota, S
    Miyamae, T
    Kurosawa, R
    Ozawa, R
    Imagawa, T
    Mori, M
    Nishimoto, N
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S725 - S725
  • [6] Long-term safety and efficacy of tocilizumab (an anti-IL-6 receptor monoclonal antibody) in monotherapy, in patients with rheumatoid arthritis
    Nishimoto, N.
    Miyasaka, N.
    Yamamoto, K.
    Kawai, S.
    Takeuchi, T.
    Azuma, J.
    Kishimoto, T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 122 - 122
  • [7] Rapid and sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in a patient with nephrotic syndrome secondary to systemic juvenile idiopathic arthritis-related amyloidosis
    De la Torre, Miguel
    Arboleya, Luis
    Pozo, Sergio
    Pinto, Jesus
    Velasco, Julio
    [J]. CLINICAL KIDNEY JOURNAL, 2011, 4 (03): : 178 - 180
  • [8] Long-Term Safety of Subcutaneous Tocilizumab Administration in Systemic and Polyarticular Juvenile Idiopathic Arthritis
    Brunner, Hermine I.
    Ruperto, Nicola
    Martini, Alberto
    Ramanan, Athimalaipet V.
    Cuttica, Ruben J.
    Weiss, Jennifer E.
    Henrickson, Michael
    Schmeling, Heinrike
    Anton, Jordi
    Minden, Kirsten
    Horneff, Gerd
    Luz Gamir-Gamir, Maria
    Hufnagel, Markus
    Douglass, Wendy
    Wells, Chris
    Wimalasundera, Sunethra
    Mallalieu, Navita L.
    Lovell, Daniel J.
    De Benedetti, Fabrizio
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [9] Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis
    Imagawa, Tomoyuki
    Yokota, Shumpei
    Mori, Masaaki
    Miyamae, Takako
    Takei, Syuji
    Imanaka, Hiroyuki
    Nerome, Yasuhito
    Iwata, Naomi
    Murata, Takuji
    Miyoshi, Mari
    Nishimoto, Norihiro
    Kishimoto, Tadamitsu
    [J]. MODERN RHEUMATOLOGY, 2012, 22 (01) : 109 - 115
  • [10] LONG-TERM SAFETY OF SUBCUTANEOUS TOCILIZUMAB ADMINISTRATION IN SYSTEMIC AND POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
    De Benedetti, Fabrizio
    Ruperto, Nicolino
    Ramanan, Athimalaipet
    Cuttica, Ruben
    Weiss, Jennifer E.
    Henrickson, Michael
    Schmeling, Heinrike
    Anton, Jordi
    Minden, Kirsten
    Horneff, Gerd
    Gamir, Maria Luz Gamir
    Hufnagel, Markus
    Douglass, Wendy
    Wells, Chris
    Mallalieu, Navita L.
    Martini, Alberto
    Lovell, Daniel J.
    Brunner, Hermine
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 548 - 548
12345